Citigroup Maintains Neutral on Bruker, Lowers Price Target to $40
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the price target from $53 to $40.
Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the price target from $53 to $40.